China Journal of Leprosy and Skin Diseases ›› 2022, Vol. 38 ›› Issue (10): 722-725.doi: 10.12144/zgmfskin202210722

• Case Reports • Previous Articles     Next Articles

Cutaneous Rosai-Dorfman disease treated successfully with thalidomide combined with local glucocorticoid injection: a case report

WANG Ying1，2，3, JIAN Dan1，3, MAO Manyun1，2，3, HUANG Yingxue1，3, CHEN Mingliang1，2，3, CHEN Wangqing1，2，3, ZHU Wu1，2，3   

  1. 1 Department of Dermatology, Xiangya Hospital, Central South University, Changsha 410008, China;
    2 Hunan Key Laboratory of Skin Cancer and Psoriasis, Changsha 410008, China;
    3 Hunan Engineering Research Center of Skin Health and Disease, Changsha 410008, China
  • Online:2022-10-15 Published:2022-08-23

PDF (PC)

149

Like

Abstract: According to the literature the treatment of cutaneous Rosai-Dorfman disease (CRDD) include antibiotics, retinoids, tripterygium wilfordii, methylprednisolone and surgery, etc. There is no a standard treatment now. We report a case of CRDD patient with multiple nodules all over the body. The skin lesions were alleviated by oral thalidomide and local injection of triamcinolone acetonide after 4-month follow up.

Key words: cutaneous Rosai-Dorfman disease, thalidomide, triamcinolone acetonide